Your browser doesn't support javascript.
loading
Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
Russkamp, Norman F; Myburgh, Renier; Kiefer, Jonathan D; Neri, Dario; Manz, Markus G.
Affiliation
  • Russkamp NF; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland.
  • Myburgh R; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland.
  • Kiefer JD; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland.
  • Neri D; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland.
  • Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Comprehensive Cancer Center Zurich (CCCZ), Zurich, Switzerland. Electronic address: markus.manz@usz.ch.
Exp Hematol ; 95: 31-45, 2021 03.
Article in En | MEDLINE | ID: mdl-33484750
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Hematopoietic Stem Cells / Proto-Oncogene Proteins c-kit / Transplantation Conditioning / Immunotherapy / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Exp Hematol Year: 2021 Document type: Article Affiliation country: Switzerland Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Hematopoietic Stem Cells / Proto-Oncogene Proteins c-kit / Transplantation Conditioning / Immunotherapy / Antineoplastic Agents Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Exp Hematol Year: 2021 Document type: Article Affiliation country: Switzerland Country of publication: Netherlands